Inventor · disambiguated record
Rico Lavoie
Also filed as: LAVOIE RICO · LAVOIE RICO C
31 granted patents·12 pending applications·647 citations·filing 2000–2017
97Inventor score
Files withBRISTOL MYERS SQUIBB CO17BACHAND CAROL6BAYER PHARMACEUTICALS CORP6BAYER HEALTHCARE LLC3LAVOIE RICO3
Top patents by PatentIndex Score
43 records- 0198US7741347B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 22, 2010·52 cites·13 claims
- 0297US8303944B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2008·Granted Nov 6, 2012·36 cites·13 claims
- 0397US7704992B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Apr 27, 2010·58 cites·25 claims
- 0497US7659270B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Feb 9, 2010·72 cites·25 claims
- 0596US7759495B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jul 20, 2010·41 cites·31 claims
- 0696US7745636B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jun 29, 2010·53 cites·26 claims
- 0796US6541661B1Inhibitors of histone deacetylaseMETHYLGENE INC·Filed 2000·Granted Apr 1, 2003·192 cites·34 claims
- 0895US8574563B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2012·Granted Nov 5, 2013·18 cites·26 claims
- 0992US8846023B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Sep 30, 2014·7 cites·13 claims
- 1092US8642025B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Granted Feb 4, 2014·12 cites·40 claims
- 1191US8147818B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2009·Granted Apr 3, 2012·22 cites·22 claims
- 1290US8143414B2Hepatitis C virus inhibitorsLAVOIE RICO·Filed 2010·Granted Mar 27, 2012·12 cites·18 claims
- 1389US8492553B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2012·Granted Jul 23, 2013·11 cites·31 claims
- 1489USRE39850EInhibitors of histone deacetylaseMETHYLGENE INC·Filed 2004·Granted Sep 18, 2007·34 cites·162 claims
- 1588US9227961B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 5, 2016·6 cites·12 claims
- 1687US8288562B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2010·Granted Oct 16, 2012·9 cites·31 claims
- 1783US9018390B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 28, 2015·4 cites·31 claims
- 1882US8093243B2Hepatitis C virus inhibitorsBACHAND CAROL·Filed 2009·Granted Jan 10, 2012·5 cites·26 claims
- 1981US9776981B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·2 cites·14 claims
- 2069US7803956B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2009·Granted Sep 28, 2010·0 cites·19 claims
- 2167USRE43343EInhibitors of histone deacetylaseDELORME DANIEL·Filed 2009·Granted May 1, 2012·0 cites·180 claims
- 2267US7659412B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER HEALTHCARE LLC·Filed 2008·Granted Feb 9, 2010·0 cites·8 claims
- 2366US8809548B2Hepatitis C virus inhibitorsROMINE JEFFREY LEE·Filed 2010·Granted Aug 19, 2014·1 cites·22 claims
- 2462US2017355689A1Hepatitis c virus inhibitorBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2561US9758487B2Hepatitis C virus inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 12, 2017·0 cites·15 claims
- 2661US7964622B2Indole acetic acid derivatives and their use as pharmaceutical agentsBAYER HEALTHCARE LLC·Filed 2009·Granted Jun 21, 2011·0 cites·13 claims
- 2761US2013115193A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 2857US2014018389A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2956US2011274648A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 3055US2015197499A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3154US7420066B2Benzofuran derivatives useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 2, 2008·0 cites·7 claims
- 3252US7592361B2Indole acetic acid derivatives and their use as pharmaceutical agentsBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 22, 2009·0 cites·20 claims
- 3352US2014205564A1Hepatitis C Virus InhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 3451US7714004B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2003·Granted May 11, 2010·0 cites·34 claims
- 3550US2006122215A1Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-C]pyridine derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 3649US7071207B2Preparation and use of 1,5,6,7-tetrahydropyrrolo[3,2-c]pyridine derivatives for treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Jul 4, 2006·0 cites·27 claims
- 3748US2011281910A1Hepatitis C Virus InhibitorsLAVOIE RICO·Filed 2010·Application pending·0 cites
- 3846US2003152557A1Methods for inhibiting histone deacetylase-4Filed 2002·Application pending·0 cites
- 3946US2003148970A1Methods for specifically inhibiting histone deacetylase-4Filed 2002·Application pending·0 cites
- 4043US7906653B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER HEALTHCARE LLC·Filed 2010·Granted Mar 15, 2011·0 cites·29 claims
- 4141US2004267028A1Preparation and use of pyrrole derivatives for treating obesitySMITH ROGER A·Filed 2002·Application pending·0 cites
- 4238US2004180891A1Pyrazole derivatives useful in the treatment of hyper-proliferative disordersFiled 2002·Application pending·0 cites
- 4334US8211928B2Hepatitis C virus inhibitorsLAVOIE RICO·Filed 2010·Granted Jul 3, 2012·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →